Treatment strategies for pediatric idiopathic hypercalciuria.
Idiopathic hypercalciuria (IH) is a common metabolic disorder in children and is associated with the development of renal calculi, nephrocalcinosis, hematuria and osteopenia. The effect of various dietary modifications and available pharmacologic therapies on reducing urinary calcium excretion and/or urinary supersaturation is discussed in this article. The importance of a multidisciplinary approach involving the patient, their families, and health-care professionals is also addressed.
Lau
Keith Kwong
KK
Department of Pediatrics, University of California, Davis, 2516 Stockton Blvd., Sacramento, CA 95817, USA. keith.lau@ucdmc.ucdavis.edu
Butani
Lavjay
L
D002136:Calcium, Dietary / Q000627:therapeutic use; D002648:Child; D019343:Citric Acid / Q000627:therapeutic use; D004044:Dietary Proteins / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D053565:Hypercalciuria / Q000178:diet therapy* / Q000188:drug therapy*; D017419:Potassium, Dietary / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D012982:Sodium, Dietary / Q000627:therapeutic use
D002136:Calcium, Dietary; D004044:Dietary Proteins; D004164:Diphosphonates; D017419:Potassium, Dietary; D049993:Sodium Chloride Symporter Inhibitors; D012982:Sodium, Dietary; D019343:Citric Acid